Compile Data Set for Download or QSAR
Report error Found 131 Enz. Inhib. hit(s) with all data for entry = 9070
TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290408((3R,4S)-3-amino-1-(2-aminocyclohexyl)-4-(3- borono...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290408((3R,4S)-3-amino-1-(2-aminocyclohexyl)-4-(3- borono...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290407((3R,4S)-3-amino-4-(3-boronopropyl)-1-((S)-pyrrolid...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290404((3R,4S)-3-amino-1-(2-(benzylamino)ethyl)-4-(3- bor...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290404((3R,4S)-3-amino-1-(2-(benzylamino)ethyl)-4-(3- bor...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290405((3R,4S)-3-amino-4-(3-boronopropyl)-1-(2-(3,4- dich...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290405((3R,4S)-3-amino-4-(3-boronopropyl)-1-(2-(3,4- dich...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290419((3R,4S)-3-amino-4-(3-boronopropyl)-1-((7-(trifluor...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290419((3R,4S)-3-amino-4-(3-boronopropyl)-1-((7-(trifluor...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290416((3R,4S)-3-amino-1-(2-(biphenyl-4-ylamino)ethyl)-4-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290416((3R,4S)-3-amino-1-(2-(biphenyl-4-ylamino)ethyl)-4-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290417((3R,4S)-3-amino-4-(3-boronopropyl)-1-(1,2,3,4- tet...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290415((3R,4S)-3-amino-4-(3-boronopropyl)-1-((6-chloro-1,...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290415((3R,4S)-3-amino-4-(3-boronopropyl)-1-((6-chloro-1,...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290413((3R,4S)-3-amino-4-(3-boronopropyl)-1-((7-chloro-1,...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290413((3R,4S)-3-amino-4-(3-boronopropyl)-1-((7-chloro-1,...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290426((1S,2S,4S)-1-amino-4-(benzylamino)-2-(3- boronopro...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290426((1S,2S,4S)-1-amino-4-(benzylamino)-2-(3- boronopro...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290427((1S,2S,4S)-1-amino-2-(3-boronopropyl)-4- (dimethyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290427((1S,2S,4S)-1-amino-2-(3-boronopropyl)-4- (dimethyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290423((3R,4S)-3-amino-4-(3-boronopropyl)-1-((5,7-dichlor...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290423((3R,4S)-3-amino-4-(3-boronopropyl)-1-((5,7-dichlor...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290413((3R,4S)-3-amino-4-(3-boronopropyl)-1-((7-chloro-1,...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290413((3R,4S)-3-amino-4-(3-boronopropyl)-1-((7-chloro-1,...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290421((3R,4S)-3-amino-1-(2-amino-3-phenylpropyl)-4-(3- b...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290421((3R,4S)-3-amino-1-(2-amino-3-phenylpropyl)-4-(3- b...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290368((2S,3S)-3-amino-2-(3-boronopropyl)tetrahydrofuran-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290368((2S,3S)-3-amino-2-(3-boronopropyl)tetrahydrofuran-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290430(US10098902, Example 66 | (1S,2S,4R)-1-amino-4-(2-a...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290430(US10098902, Example 66 | (1S,2S,4R)-1-amino-4-(2-a...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290428(US10098902, Example 64 | (1S,2S,4R)-1-amino-4-(ami...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290428(US10098902, Example 64 | (1S,2S,4R)-1-amino-4-(ami...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290378((3R,4S)-3-amino-1-(2-aminocyclopentyl)-4-(3- boron...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290378((3R,4S)-3-amino-1-(2-aminocyclopentyl)-4-(3- boron...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM438857((3R,4S)-1-((1H-imidazol-4-yl)methyl)-3-amino-4-(3-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290385((3R,4S)-3-amino-4-(3-boronopropyl)-1-(piperidin-2-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290385((3R,4S)-3-amino-4-(3-boronopropyl)-1-(piperidin-2-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290382((3R,4S)-3-amino-4-(3-boronopropyl)-1-(piperidin-3-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290380((3R,4S)-3-amino-4-(3-boronopropyl)-1-(3-(4- carbox...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290380((3R,4S)-3-amino-4-(3-boronopropyl)-1-(3-(4- carbox...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290395((3R,4S)-3-amino-4-(3-boronopropyl)-1-((1-methyl-1H...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290392((3R,4S)-3-amino-4-(3-boronopropyl)-1-(piperidin-3-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290391((3R,4S)-3-amino-4-(3-boronopropyl)-1,3'-bipyrrolid...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290391((3R,4S)-3-amino-4-(3-boronopropyl)-1,3'-bipyrrolid...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290388((3R,4S)-3-amino-1-(2-aminoethyl)-4-(3-boronopropyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290388((3R,4S)-3-amino-1-(2-aminoethyl)-4-(3-boronopropyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290402((3R,4S)-3-amino-4-(3-boronopropyl)-1-(2-(pyrrolidi...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290402((3R,4S)-3-amino-4-(3-boronopropyl)-1-(2-(pyrrolidi...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-2, mitochondrial(Human)
Mars

US Patent
LigandPNGBDBM290403((3R,4S)-3-amino-4-(3-boronopropyl)-1-(((S)-1,2,3,4...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

TargetArginase-1(Human)
Mars

US Patent
LigandPNGBDBM290403((3R,4S)-3-amino-4-(3-boronopropyl)-1-(((S)-1,2,3,4...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent

Displayed 1 to 50 (of 131 total ) | Next | Last >>
Jump to: